Cerecor Inc (NASDAQ:CERC)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - CERC

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - CERC

  • Market Cap$239.810m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS15671L1098

Company Profile

Cerecor Inc is a biopharmaceutical company with commercial operations and research and development capabilities. The Company is building a robust pipeline of innovative therapies in neurology, pediatric healthcare, and orphan rare diseases. The Company is also developing three other neurological clinical and preclinical stage compounds. The Company's pediatric orphan rare disease pipeline is led by CERC-801, CERC-802 and CERC-803. The Company also markets prescription drugs that treat a range of pediatric diseases, disorders and conditions. Cerecor's prescription drugs include Millipred®, Ulesfia®, Karbinal™ ER, AcipHex® Sprinkle™ and Cefaclor for Oral Suspension. The Company has marketed medical device, Flexichamber™.Cerecor Inc is a clinical stage biopharmaceutical company which is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The company owns a right to COMTi platform.

Latest CERC news

Currently there for this company. Visit our news hub for other news .